Arrowhead Pharmaceuticals Inc. (ARWR) Reports Q1 Loss of $0.20
Tweet
Share
E-mailGet Alerts ARWR Hot Sheet
Price: $68.79 +3.47%
Financial Fact:
Change in value of derivatives: -113.36K
Today's EPS Names:
ALZN, ASPU, OCCI, More
Financial Fact:
Change in value of derivatives: -113.36K
Today's EPS Names:
ALZN, ASPU, OCCI, More
Join SI Premium – FREE
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported Q1 EPS of ($0.20), versus ($0.03) reported last year. Revenue for the quarter came in at $21.3 million, versus $29.46 million reported last year.
For earnings history and earnings-related data on Arrowhead Pharmaceuticals Inc. (ARWR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Raymond James Reiterates Underperform Rating on Lennar (LEN)
- AMC Entertainment launches tender offer for $360M in senior notes
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
